76 related articles for article (PubMed ID: 10561251)
1. Male breast cancer: Outcome with adjuvant treatment.
Yadav BS; Sharma SC; Singh R; Dahiya D; Ghoshal S
J Cancer Res Ther; 2020; 16(6):1287-1293. PubMed ID: 33342786
[TBL] [Abstract][Full Text] [Related]
2. High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil.
Polho GB; Cunha MT; Coelho MHM; Almeida-Silva J; Hidalgo Filho CM; Xavier EM; Crusoe NS; Atanazio MJ; de Vasconcellos VF; Horita VN; Freitas GF; Muniz DQ; Rocha V; Mota JM
Clin Genitourin Cancer; 2024 Jun; 22(3):102083. PubMed ID: 38658209
[TBL] [Abstract][Full Text] [Related]
3. A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast.
Thériault K; Ben Moussa M; Perron M; Desbiens C; Poirier B; Poirier É; Leblanc D; Morin C; Lemieux J; Hogue JC; Boudreau D
Breast J; 2024; 2024():5920505. PubMed ID: 38223556
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.
Peinemann F; Kröger N; Bartel C; Grouven U; Pittler M; Erttmann R; Kulig M
PLoS One; 2011 Feb; 6(2):e17127. PubMed ID: 21373200
[TBL] [Abstract][Full Text] [Related]
5. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda.
Gakwaya A; Kigula-Mugambe JB; Kavuma A; Luwaga A; Fualal J; Jombwe J; Galukande M; Kanyike D
Br J Cancer; 2008 Jul; 99(1):63-7. PubMed ID: 18577991
[TBL] [Abstract][Full Text] [Related]
6. A way forward on the medically appropriate use of white cell growth factors.
Smith TJ; Hillner BE
J Clin Oncol; 2012 May; 30(14):1584-7. PubMed ID: 22370327
[No Abstract] [Full Text] [Related]
7. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy.
Grossarth-Maticek R; Eysenck HJ
Psychol Rep; 1989 Aug; 65(1):315-21. PubMed ID: 2780939
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.
Cheng YC; Shi Y; Zhang MJ; Brazauskas R; Hemmer MT; Bishop MR; Nieto Y; Stadtmauer E; Ayash L; Gale RP; Lazarus H; Holmberg L; Lill M; Olsson RF; Wirk BM; Arora M; Hari P; Ueno N
J Cancer; 2017; 8(6):1009-1017. PubMed ID: 28529613
[No Abstract] [Full Text] [Related]
9. Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.
Boudin L; Gonçalves A; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Chabannon C
J Cancer; 2016; 7(14):2077-2084. PubMed ID: 27877223
[No Abstract] [Full Text] [Related]
10. Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.
Sportès C; Steinberg SM; Liewehr DJ; Gea-Banacloche J; Danforth DN; Avila DN; Bryant KE; Krumlauf MC; Fowler DH; Pavletic S; Hardy NM; Bishop MR; Gress RE
Biol Blood Marrow Transplant; 2009 Aug; 15(8):963-70. PubMed ID: 19589486
[TBL] [Abstract][Full Text] [Related]
11. Premenopausal breast cancer: chemotherapy and endocrine therapy.
Sayer HG; Kath R; Kliche KO; Höffken K
Drugs; 2002; 62(14):2025-38. PubMed ID: 12269848
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D
Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
Cagnoni PJ; Nieto Y; Shpall EJ; Bearman SI; Barón AE; Ross M; Matthes S; Dunbar SE; Jones RB
J Clin Oncol; 1998 May; 16(5):1661-8. PubMed ID: 9586876
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced breast cancer.
Sikov WM
Curr Treat Options Oncol; 2000 Aug; 1(3):228-38. PubMed ID: 12057165
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
Adkins D; Brown R; Trinkaus K; Maziarz R; Luedke S; Freytes C; Needles B; Wienski D; Fracasso P; Pluard T; Moriconi W; Ryan T; Hoelzer K; Safdar S; Rearden T; Rodriguez G; Khoury H; Vij R; DiPersio J
J Clin Oncol; 1999 Jul; 17(7):2006-14. PubMed ID: 10561251
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.
Somlo G; Doroshow JH; Forman SJ; Odom-Maryon T; Lee J; Chow W; Hamasaki V; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Simpson J; Molina A
J Clin Oncol; 1997 Aug; 15(8):2882-93. PubMed ID: 9256132
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
